Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

TNF Pharmaceuticals Current Ratio 2012-2024 | TNFA

TNF Pharmaceuticals current ratio from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
TNF Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-06-30 $0.01B $0.01B 2.48
2024-03-31 $0.00B $0.00B 0.62
2023-12-31 $0.01B $0.01B 1.17
2023-09-30 $0.01B $0.01B 1.71
2023-06-30 $0.01B $0.00B 5.41
2023-03-31 $0.02B $0.00B 10.02
2022-12-31 $0.01B $0.00B 1.95
2022-09-30 $0.01B $0.00B 4.54
2022-06-30 $0.01B $0.00B 2.41
2022-03-31 $0.01B $0.00B 4.08
2021-12-31 $0.01B $0.00B 12.18
2021-09-30 $0.02B $0.00B 7.62
2021-06-30 $0.02B $0.00B 6.68
2021-03-31 $0.03B $0.00B 14.45
2020-12-31 $0.00B $0.00B 0.06
2020-09-30 $0.02B $0.00B 9.22
2020-06-30 $0.02B $0.00B 6.83
2020-03-31 $0.01B $0.00B 3.81
2019-12-31 $0.01B $0.00B 6.74
2019-09-30 $0.00B $0.00B 3.14
2019-06-30 $0.01B $0.00B 3.25
2019-03-31 $0.01B $0.00B 2.87
2018-12-31 $0.01B $0.00B 3.38
2018-09-30 $0.01B $0.00B 3.44
2018-06-30 $0.01B $0.00B 5.71
2018-03-31 $0.01B $0.00B 8.09
2017-12-31 $0.01B $0.00B 4.36
2017-09-30 $0.00B $0.00B 2.35
2017-06-30 $0.01B $0.00B 3.15
2017-03-31 $0.01B $0.00B 3.92
2016-12-31 $0.00B $0.00B 1.88
2016-09-30 $0.00B $0.00B 2.94
2016-06-30 $0.00B $0.00B 2.51
2016-03-31 $0.01B $0.00B 3.13
2015-12-31 $0.01B $0.00B 3.88
2015-09-30 $0.01B $0.00B 6.57
2015-06-30 $0.01B $0.00B 8.48
2015-03-31 $0.01B $0.00B 10.26
2014-12-31 $0.01B $0.00B 7.08
2014-09-30 $0.01B $0.00B 14.32
2014-06-30 $0.02B $0.00B 15.69
2014-03-31 $0.02B $0.00B 16.08
2013-12-31 $0.00B $0.00B 2.05
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B $0.00B 1.17
2011-12-31 $0.00B $0.00B 3.64
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.000B
TNF Pharmaceuticals Inc. is a clinical stage pharmaceutical company committed to extending healthy lifespan. It focused on developing novel therapeutic platforms which treat the causes of disease rather than only addressing the symptoms. TNF Pharmaceuticals Inc., formerly known as MyMD Pharmaceuticals Inc., is based in BALTIMORE.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $85.731B 34.16
Takeda Pharmaceutical (TAK) Japan $47.124B 9.43
Merck (MKGAF) Germany $24.039B 26.23
Astellas Pharma (ALPMY) Japan $22.440B 26.96
Sandoz Group AG (SDZNY) Switzerland $18.283B 0.00
United Therapeutics (UTHR) United States $15.377B 15.88
Shionogi (SGIOY) Japan $13.368B 12.81
Neurocrine Biosciences (NBIX) United States $12.134B 36.31
Catalent (CTLT) United States $10.861B 0.00
Summit Therapeutics (SMMT) United States $8.890B 0.00
Orion OYJ (ORINY) Finland $7.339B 29.89
Revolution Medicines (RVMD) United States $6.989B 0.00
Ionis Pharmaceuticals (IONS) United States $6.856B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.616B 7.02
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.717B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.296B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.033B 0.00
Corcept Therapeutics (CORT) United States $3.592B 30.42
Dyne Therapeutics (DYN) United States $3.316B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.762B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.597B 14.98
PTC Therapeutics (PTCT) United States $2.426B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.326B 18.49
Soleno Therapeutics (SLNO) United States $1.887B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.664B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.651B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.618B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.476B 0.00
Indivior (INDV) United States $1.427B 6.55
Avadel Pharmaceuticals (AVDL) Ireland $1.395B 0.00
Harrow (HROW) United States $1.348B 0.00
Ardelyx (ARDX) United States $1.318B 0.00
Ocular Therapeutix (OCUL) United States $1.308B 0.00
Cassava Sciences (SAVA) United States $1.291B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.221B 0.00
Collegium Pharmaceutical (COLL) United States $1.198B 6.87
Evotec AG (EVO) Germany $1.191B 0.00
ARS Pharmaceuticals (SPRY) United States $1.101B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.038B 0.00
Enliven Therapeutics (ELVN) United States $1.013B 0.00
Xencor (XNCR) United States $0.998B 0.00
Relay Therapeutics (RLAY) United States $0.835B 0.00
Cronos Group (CRON) Canada $0.818B 0.00
4D Molecular Therapeutics (FDMT) United States $0.783B 0.00
Bioventus (BVS) United States $0.772B 25.08
Savara (SVRA) United States $0.728B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.720B 45.10
USANA Health Sciences (USNA) United States $0.718B 13.18
ProKidney (PROK) United States $0.675B 0.00
Pacira BioSciences (PCRX) United States $0.639B 6.05
Exscientia (EXAI) United Kingdom $0.622B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.603B 0.00
Silence Therapeutics (SLN) United Kingdom $0.558B 0.00
Siga Technologies (SIGA) United States $0.550B 6.59
KalVista Pharmaceuticals (KALV) United States $0.532B 0.00
Larimar Therapeutics (LRMR) United States $0.514B 0.00
Eliem Therapeutics (ELYM) United States $0.496B 0.00
Verve Therapeutics (VERV) United States $0.473B 0.00
OmniAb (OABI) United States $0.469B 0.00
Sage Therapeutics (SAGE) United States $0.458B 0.00
Altimmune (ALT) United States $0.441B 0.00
Foghorn Therapeutics (FHTX) United States $0.417B 0.00
Tourmaline Bio (TRML) United States $0.394B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.392B 0.00
Zevra Therapeutics (ZVRA) United States $0.385B 0.00
Aquestive Therapeutics (AQST) United States $0.381B 0.00
Korro Bio (KRRO) United States $0.379B 0.00
Xeris Biopharma Holdings (XERS) United States $0.374B 0.00
Aldeyra Therapeutics (ALDX) United States $0.364B 0.00
Lexeo Therapeutics (LXEO) United States $0.360B 0.00
Elite Pharmaceuticals (ELTP) United States $0.335B 31.35
Organogenesis (ORGO) United States $0.327B 0.00
Esperion Therapeutics (ESPR) United States $0.324B 0.00
Black Diamond Therapeutics (BDTX) United States $0.305B 0.00
Lyell Immunopharma (LYEL) United States $0.300B 0.00
Akebia Therapeutics (AKBA) United States $0.284B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Prelude Therapeutics (PRLD) United States $0.267B 0.00
Acrivon Therapeutics (ACRV) United States $0.250B 0.00
Nanobiotix S.A (NBTX) France $0.250B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.245B 0.00
Nature's Sunshine Products (NATR) United States $0.242B 16.52
ESSA Pharma (EPIX) Canada $0.239B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.230B 0.00
Nektar Therapeutics (NKTR) United States $0.206B 0.00
Pyxis Oncology (PYXS) United States $0.206B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
CytoDyn (CYDY) United States $0.182B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Context Therapeutics (CNTX) United States $0.174B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.161B 0.00
VAXART, INC (VXRT) United States $0.157B 0.00
Galectin Therapeutics (GALT) United States $0.153B 0.00
Telomir Pharmaceuticals (TELO) United States $0.152B 0.00
Fractyl Health (GUTS) United States $0.150B 0.00
OptiNose (OPTN) United States $0.143B 0.00
Achieve Life Sciences (ACHV) Canada $0.143B 0.00
Cardiol Therapeutics (CRDL) Canada $0.128B 0.00
Century Therapeutics (IPSC) United States $0.124B 0.00
Assertio Holdings (ASRT) United States $0.120B 21.00
Incannex Healthcare (IXHL) Australia $0.105B 0.00
Metagenomi (MGX) United States $0.102B 0.00
CASI Pharmaceuticals (CASI) China $0.101B 0.00
Journey Medical (DERM) United States $0.097B 0.00
Citius Pharmaceuticals (CTXR) United States $0.096B 0.00
Regulus Therapeutics (RGLS) United States $0.096B 0.00
Karyopharm Therapeutics (KPTI) United States $0.091B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Relmada Therapeutics (RLMD) United States $0.072B 0.00
Arch Biopartners (ACHFF) Canada $0.071B 0.00
Vivani Medical (VANI) United States $0.065B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.054B 0.00
ProPhase Labs (PRPH) United States $0.052B 0.00
Nutriband (NTRB) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
DURECT (DRRX) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Protara Therapeutics (TARA) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.037B 0.00
Inotiv (NOTV) United States $0.035B 0.00
Unicycive Therapeutics (UNCY) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.031B 0.00
Surrozen (SRZN) United States $0.030B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
Gain Therapeutics (GANX) United States $0.027B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MEI Pharma (MEIP) United States $0.021B 0.79
TherapeuticsMD (TXMD) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Aptorum Group (APM) United Kingdom $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Indaptus Therapeutics (INDP) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Conduit Pharmaceuticals (CDT) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.012B 0.00
Oncternal Therapeutics (ONCT) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Viracta Therapeutics (VIRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Avalo Therapeutics (AVTX) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Ainos (AIMD) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.73
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.57